4.00Open4.10Pre Close1 Volume105 Open Interest10.00Strike Price400.00Turnover288.89%IV1.80%PremiumAug 16, 2024Expiry Date3.89Intrinsic Value100Multiplier25DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type-0.6057Delta0.0835Gamma1.29Leverage Ratio-0.0347Theta-0.0048Rho-0.78Eff Leverage0.0062Vega
Sana Biotechnology Stock Discussion
• Editing Genes | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• Creating Therapies | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• Building DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• Dis...
• $Repare Therapeutics(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage(PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology(CRDO.US)$ +10.2% (In reaction ...
SANA announced an initial payment of 50M using Beam's Cas12b system.
It's great for Beam that Cas12b, which Beam doesn't use, is being asked for. The strangest thing is that SANA only needs Cas12b, not Base Editor. It's hard to understand! ?
No comment yet